Navigation Links
Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Date:1/31/2008

SAN DIEGO, Jan. 31 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York on Wednesday, February 6, 2008 at 1:00 p.m. ET / 10:00 a.m. PT. Mark G. Foletta, Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,900 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- New programme aims to help ... and chemical sectors Pfizer Asia Pacific ... Siemens Pte. Ltd, have signed on as founding ... - Innovative Processing of Specialties and Pharmaceuticals (iPSP). ... Sciences (ICES), the consortium offers a platform for ...
(Date:6/19/2013)... June 19, 2013 For an eco-friendly ... Waterless Bead Baths using metallic beads instead of ... and do not require germicides. Yet, the bead bath ... the bath is always ready unlike a water bath, ... a dry bath, which eliminates the contamination and maintenance ...
(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...
(Date:6/19/2013)... An article posted earlier this week by Fox ... for probiotics. The article stated that while many products are ... beeb listed, the actual use for probiotics may go ... While the total uses of probiotics have not yet been ... these “miracle” bacterium, and debunked the myths surrounding them. ...
Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2
... Pharma, an emerging biotech,company focused on developing ... data demonstrating that its enzyme,replacement therapy (ERT) ... already been severely weakened by the disease. ... product ENB-0040, significantly,increases survival and prevents bone ...
... Commentary and How-To, Communications Tools; and ... ALTO, Calif., Sept. 15 Lena Chow, a ... has,launched a new website, http://www.cityofparis.us, to ... share thinking, gain insights and,connect with their peers. ...
... SHENYANG, China, Sept. 15 3SBio Inc. (Nasdaq:,SSRX), ... manufacturing and marketing biopharmaceutical products, today,announced the results ... General,Meeting of Shareholders held on September 12, 2008 ... meeting, the Company,s shareholders re-elected Dr. Jing Lou,Liping ...
Cached Biology Technology:Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:6/19/2013)... June 19, 2013   Mercy Medical ... diagnostics technology for conducting on-demand, Hemoglobin A ... as well as analysis of important red ... counts. The new system enables the hospital ... for physicians and their patients, which can ...
(Date:6/19/2013)... (SACRAMENTO, Calif.) A study of the patients ... fungus Exserohilum rostratum from the New England Compounding ... infections even though they did not experience a ... imaging (MRI) can help detect infection, especially among ... lots. , The study, along with an ...
(Date:6/19/2013)... Mass. In the cover story for the journal ... colleagues at the University of Massachusetts Amherst describe a ... to study the function of individual proteins in individual ... advance should allow deeper insights into protein function, Chase ... of what that single protein does when we isolate ...
Breaking Biology News(10 mins):Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4Evolution of an outbreak: Complications from contaminated steroid injections 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3
... to predict the impact of climate change on the dengue ... that could help limit its spread. According to ... Ecological Society,s journal Functional Ecology , climate change and ... mosquito,s range. But human behaviour in the form of ...
... 2009. The Alfred Wegener Institute for Polar and ... the ongoing Polarstern expedition LOHAFEX". Independent scientific and ... Education and Research and the Federal Ministry for ... that the iron fertilisation experiment LOHAFEX is neither ...
... leading provider of,embedded speech solutions today announced the ... AG, according to SVOX CEO Volker Jantzen.,SVOX has ... developed,over 25 years, including the SpeechAdvance(TM) speech recognition ... majority of the Professional,Speech Processing Group,s employees will ...
Cached Biology News:Hoarding rainwater could 'dramatically' expand range of dengue-fever mosquito 2Polarstern expedition 'LOHAFEX' can be conducted 2Polarstern expedition 'LOHAFEX' can be conducted 3SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2
UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
Biology Products: